Stay updated on TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.

Latest updates to the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.5.2 has been added and v3.5.0 removed, indicating a minor version patch to the site.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check77 days agoChange DetectedNew site revision tag v3.4.2 is now shown; the older government funding status notices have been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedAdded a government funding lapse notice and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check91 days agoChange DetectedAdded glossary visibility, updated labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updated the revision to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.